CARDIOVASC ist die führende interdisziplinäre Fort- und Weiterbildungszeitschrift im Bereich der kardiovaskulären Risiken und Erkrankungen.
CARDIOVASC
- 1 minute read
You May Also Like
- Polycystic ovary syndrome 2025/2026
New pathophysiology, updated diagnostics and the age of incretin mimetics
- Heart failure and type 2 diabetes
Oral semaglutide and cardiac decompensation in type 2 diabetes
- New evidence on descensus, urinary incontinence and the future of reconstruction
Urogynecology and pelvic floor surgery 2026
- Proteins in wound healing
Do special amino acids lead to success?
- Case study
Autosomal recessive polycystic kidney disease: atypical phenotype
- Current evidence, risk classes and new counseling options
Hormonal contraception and cardiovascular risk
- Acute otitis media: self-limiting course vs. "red flags"
In which cases are antibiotics necessary?
- MACE risk, heart failure incidence and all-cause mortality